Rapid induction of skin and mammary tumors in human c-Ha-ras photo-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate

Cancer Science

Volumn 95, Issue 3, 2004, Pages 205-210

  Park, Cheol Beom ^a,d   Fukamachi, Katsumi ^d   Takasuka, Nobuo ^d   Han, Beom Seok ^b,d   Kim, Chuel Kyu ^b,d   Hamaguchi, Tetsuya ^d   Fujita, Ken Ichi ^d   Ueda, Shinobu ^d   Tsuda, Hiroyuki ^c,d  

^a Biotoxtech Co Ltd   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ONCOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER INCIDENCE; CELL POPULATION; CHEMICAL CARCINOGENESIS; CODON; CONTROLLED STUDY; FEMALE; GENE MUTATION; MALE; MAMMARY GLAND; NONHUMAN; ONCOGENE C H RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCROTUM; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; TRANSGENICS; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BENZ(A)ANTHRACENES; CARCINOGENS; FEMALE; GENES, RAS; HUMANS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RATS; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 1842845052     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb02204.x     Document Type: Article

References (33)

1. Ando K, Saitoh A, Hino O, Takahashi R, Kimura M, Katsuki M. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res 1992; 52: 978-82.
2. Mitsumori K, Koizumi H, Nomura T, Yamamoto S. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol 1998; 26: 520-31.
3. Doi ST, Kimura M, Katsuki M. Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice. Jpn J Cancer Res 1994; 85: 801-7.
4. Tsunematsu S, Saito H, Kagawa T, Morizane T, Hata J, Nakamura T, Ishii H, Tsuchiya M, Nomura T, Katsuki M. Hepatic tumors induced by carbon tetrachloride in transgenic, mice carrying a human c-H-ras proto-oncogene without mutations. Int J Cancer 1994; 59: 554-9.
5. Yamamoto S, Mitsumori K, Kodama Y, Matsunuma N, Manabe S, Okiyama H, Suzuki H, Fukuda T, Sakamaki Y, Sunaga M, Nomura G, Hioki K, Wakana S, Nomura T, Hayashi Y. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis 1996; 17: 2455-61.
6. Yamamoto S, Urano K, Koizumi H, Wakana S, Hioki K, Mitsumori K, Kurakawa Y, Hayashi Y, Nomura T. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ Health Perspect 1998; 106 Suppl. 1: 56-69.
7. Tsuda H, Moore MA, Asamoto M, Inoue T, Ito N, Satoh K, Ichihara A, Nakamura T, Amelizad Z, Oesch F. Effect of modifying agents on the phenotypic expression of cytochrome P-450, glutathione S-transferase molecular forms, microsomal epoxide hydrolase, glucose-6-phosphate dehydrogenase and gamma-glutamyltranspeptidase in rat liver preneoplastic lesions. Carcinogenesis 1988; 9: 547-54.
8. Tatematsu M, Mera Y, Ito N, Satoh K, Sato K. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis 1985; 6: 1621-6.
9. Haas MJ, Sattler CA, Dragan YP, Gast WL, Pitot HC. Multiple polypeptide hormone expression in pancreatic islet cell carcinomas derived from phosphoenolpyruvatecarboxykinase-SV40 T antigen transgenic rats. Pancreas 2000; 20: 206-14.
10. Asamoto M, Hokaiwado N, Cho YM, Shirai T. Effects of genetic background on prostate and taste bud carcinogenesis due to SV40 T antigen expression under probasin gene promoter control. Carcinogenesis 2000; 23: 463-7.
11. Asamoto M, Hokaiwado N, Cho YM, Takahashi S, Ikeda Y, Imaida K, Shirai T. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res 2001; 61: 4693-700.
12. Asamoto M, Ochiya T, Toriyama-Baba H, Ota T, Sekiya T, Terada M, Tsuda H. Transgenic, rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis. Carcinogenesis 2000; 21: 243-9.
13. Tsuda H, Asamoto M, Ochiya T, Toriyama-Baba H, Naito A, Ota T, Sekiya T, Terada M. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis. Murat Res 2000; 477: 173-82.
14. Ota T, Asamoto M, Toriyama-Baba H, Yamamoto F, Matsuoka Y, Ochiya T, Sekiya T, Terada M, Akaza H, Tsuda H. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis. Carcinogenesis 2000; 21: 1391-6.
15. Asamoto M, Toriyama-Baba H, Ohnishi T, Naito A, Ota T, Ando A, Ochiya T, Tsuda H. Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis. Jpn J Cancer Res 2002; 93: 744-51.
16. Han BS, Fukamachi K, Takasuka N, Ohnishi T, Maeda M, Yamasaki T, Tsuda H. Inhibitory effects of 17beta-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats. Carcinogenesis 2002; 23: 1209-15.
17. Asamoto M, Ota T, Toriyama-Baba H, Hokaiwado N, Naito A, Tsuda H. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment. Jpn J Cancer Res 2002; 93: 32-35.
18. Wilson JS, Holland LM. Periodic response difference in mouse epidermis chronically exposed to crude-oils or BaP: males vs. females. Toxicology 1988; 50: 83-94.
19. Rasmussen KS, Glenthoj A, Arffmann E. Skin carcinogenesis in rats by 3-methylcholanthrene and 7,12-dimethylbenz(alpha)anthracene. Influence of dose and frequency on tumour response and its histological type. Acta Pathol Microbiol Immunol Scand A 1983; 91: 445-55.
20. Schweizer J, Loehrke H, Hesse B, Goerttler K. 7,12-Dimethylbenz[a]-anthracene/12-O-tetradecanoylphorbol-13-acetate- mediated skin tumor initiation and promotion in male Sprague-Dawley rats. Carcinogenesis 1982; 3: 785-9.
21. Zackheim HS, Fu KK, Chan AS. Lack of effect of supplemental dietary selenium on time to development of radiation-induced cutaneous tumors in rats. Cancer Lett 1993; 70: 123-7.
22. Zabezhinski MA, Pliss GB, Okulov VB, Petrov AS. Skin tumours induced by local and systemic action of N-nitroso-compounds in rats. Arrh Geschwulstforsch 1985; 55: 117-22.
23. Rehman I, Lowry DT, Adams C, Abdel-Fattah R, Holly A, Yuspa SH, Hennings H. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N′-nitro-N-nitrosoguanidine and promoted by mezerein. Mol Carcinog 2000; 27: 298-307.
24. Saitoh A, Kimura M, Takahashi R, Yokoyama M, Nomura T, Izawa M, Sekiya T, Nishimura S, Katsuki M. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 1990; 5: 1195-200.
25. Pazzaglia S, Mancuso M, Primerano B, Rebessi S, Biozzi G, Covelli V, Saran A. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone. Mol Carcinog 2001; 30: 111-8.
26. Pazzaglia S, Mancuso M, Rebessi S, Di Majo V, Tanori M, Biozzi G, Covelli V, Saran A. The genetic control of chemically and radiation-induced skin tumorigenesis: a study with carcinogenesis-susceptible and carcinogenesis-resistant mice. Radiat Res 2002; 158: 78-83.
27. Battalora MS, Spalding JW, Szczesniak CJ, Cape JE, Morris RJ, Trempus CS, Bortner CD, Lee BM, Tennant RW. Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse. Carcinogenesis 2001; 22: 651-9.
28. Rodriguez-Puebla ML, LaCava M, Bolontrade MF, Russell J, Conti CJ. Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin. Mol Carcinog 1999; 26: 150-6.
29. Ise K, Nakamura K, Nakao K, Shimizu S, Harada H, Ichise T, Miyoshi J, Gondo Y, Ishikawa T, Aiba A, Katsuki M. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 2000; 19: 2951-6.
30. Trempus CS, Bishop WR, Njoroge FG, Doll RJ, Battalora MS, Mahler JF, Haseman JK, Tennant RW. A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse. Mol Carcinog 2000; 27: 24-33.
31. Casanova ML, Larcher F, Casanova B, Murillas R, Fernandez-Acenero MJ, Villanueva C, Martinez-Palacio J, Ullrich A, Conti CJ, Jorcano JL. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res 2002; 62: 3402-7.
32. Thompson TA, Haag JD, Lindstrom MJ, Griep AE, Lohse JK, Gould MN. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter. Oncogene 2002; 18: 2797-804.
33. Matsuoka Y, Hamaguchi T, Toriyama-Baba H, Fukamachi K, Kawaguchi H, Kusunoki M, Yoshida H, Tsuda H. Rapid emergence of mammary preneoplastic and malignant lesions in human c-Ha-ras proto-oncogene transgenic rats: possible application for screening of chemopreventive agents. Toxicol Pathol 2003; 31: in press.